/Companies

Nomic Bio

YC W20

Montreal, CA · Founded 2017 · 100 employees · Hiring · 18 known investors

Find your way into Nomic Bio

Sign up to see every warm intro you have to Nomic Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Nomic Bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Nomic offers an end-to-end protein profiling service built on its nELISA technology, quantifying up to 1000 informative proteins with absolute quantification for research studies. It targets researchers doing proteomics work, aiming for high-throughput, low-cost profiling in the biotech and life sciences market.

Also known as 10408875 CANADA INC. · nplex biosciences

Founders & leadership· Y Combinator alumni (W20)

Nomic Bio was founded in 2017 by Milad Dagher and Jeff Munzar.

MDMilad Dagher
Milad DagherCo-Founder & CEO
JMJeff Munzar
Jeff MunzarCo-founder
EK
Elisha KraussOperations Managerformer
AM
Ani MuradyanRecruiterformer

Investors · 18

Casdin CapitalreportedNew York

How we know: betakit.com · Y Combinator's founder network · Not right? Tell us

First Star Venturesreported

How we know: Y Combinator's founder network · Not right? Tell us

Lux CapitalreportedNew York · $100K – $100M

How we know: funding news · betakit.com · Y Combinator's founder network · Not right? Tell us

SR One Capital ManagementreportedRedwood City

How we know: Y Combinator's founder network · Not right? Tell us

TechU VenturesreportedCedarhurst

How we know: Y Combinator's founder network · Not right? Tell us

Tencent HoldingsreportedShenzhen

How we know: Y Combinator's founder network · Not right? Tell us

UNCOMMON DENOMINATORreportedNew York

How we know: Y Combinator's founder network · Not right? Tell us

Village GlobalreportedCovina · $500K – $3M

How we know: Y Combinator's founder network · Not right? Tell us

Also in the syndicate · 2

SR OneYCombinator

Funding

SEC filings, press & company announcements

$42M disclosed across 1 of 2 rounds · 2021–2024

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

2 people who came through Nomic Bio went on to found or lead other companies.

Related companies · 10

AryllaArylla produces invisible ink tags using nanotechnology that can be applied to fashion products and read via smartphone to enable authentication, traceability, and personalized customer experiences. The tags integrate with third-party platforms like WeChat and WhatsApp to connect consumers with branded content and product verification.
Helix NanotechnologiesHelix Nanotechnologies develops mRNA-based therapeutics for disease treatment and environmental applications, currently advancing a COVID-19 vaccine candidate for immunocompromised patients and testing interventions targeting climate challenges.
Phenomic AIPhenomic AI is a biotech company developing therapies for solid tumors using a machine-learning-powered transcriptomics platform that analyzes single-cell RNA data to identify drug targets and understand tumor biology. The company develops antibody-based therapies informed by its analysis of cell-cell interactions in tumor microenvironments, with current programs targeting stromal and immune components of difficult-to-treat cancers.
Kern SystemsKern Systems develops a cold data storage platform using synthetic DNA molecules and enzymes to archive data with superior density, durability, and energy efficiency compared to traditional storage technologies. The platform targets the growing market for long-term archival storage of rarely-accessed unstructured data.
spotLESS MaterialsspotLESS Materials develops nature-inspired liquid-entrenched smooth surface (LESS) coatings that repel liquids, sludge, and contaminants while enabling self-cleaning properties for industrial applications including sanitation, automotive, and medical sectors.
IDbyDNAScalable, high throughput DNA sequencing platforms.
KeylikaKeylika develops a platform synthesis technology for mixed ligand metal complexes to generate organometallic drugs for treating therapeutic conditions including hematology, pain, inflammation, metabolic disorders, infectious diseases, and oncology. The company combines drug development with drug delivery technologies, customizing molecular structure and formulation to optimize clinical outcomes for women, children, elderly, and patients with specific diseases.
NeoGenomicsNeoGenomics develops diagnostic tests and tools for cancer care, including tests for immunotherapy response monitoring, therapy selection, and minimal residual disease detection.
Genomics PlcGenomics builds a genotype-phenotype database and genetic risk-prediction tools used to support pharmaceutical drug discovery and clinical trials, as well as population health management and clinical decision support for healthcare providers. It serves life sciences companies and healthcare systems through its Life Sciences and Health & Wellness divisions.
VerinomicsVerinomics develops crop improvement technology by combining genomics, computational biology, and a transgene-free gene editing platform, with an AI-driven population genomics tool to identify high-value trait genes. It serves breeding programs, agricultural businesses, and research institutions focused on specialty and vegetatively propagated crops such as leafy greens.

Companies working in the same space as Nomic Bio.

Legal entities · 1

corporate structure
10408875 CANADA INC.

In the news

Frequently asked questions

What does Nomic Bio do?
Nomic offers an end-to-end protein profiling service built on its nELISA technology, quantifying up to 1000 informative proteins with absolute quantification for research studies. It targets researchers doing proteomics work, aiming for high-throughput, low-cost profiling in the biotech and life sciences market.
Who founded Nomic Bio?
Nomic Bio was founded by Milad Dagher, Jeff Munzar in 2017.
Who are Nomic Bio's investors?
Nomic Bio's investors include Amplitude Venture Capital, Avant Bio, First Star Ventures, Front Row Ventures, Raptor Group, Y Combinator, 2048 Ventures, BoxOne Ventures and 8 more.
How much funding has Nomic Bio raised?
Nomic Bio has disclosed $42M raised across 1 of its 2 known rounds.
Where is Nomic Bio headquartered?
Nomic Bio is headquartered in Montreal, CA.